Dose-Dependency and Rate of Decay of Efficacy of Resovist on MR Images in a Rat Cirrhotic Liver Model

Abstract

Kato N, Takahashi M, Tsuji T, Ihara S, Brautigam M, Miyazawa T. Dose-dependency and rate of decay of efficacy of Resovist on MR images in a rat cirrhotic liver model. Invest Radiol 1999;34:551–557.

RATIONALE AND OBJECTIVES. 

To investigate the dose-dependency and half-life of decay of the signal reduction by superparamagnetic iron oxides on three different spin-echo images in a rat model of cirrhosis.

METHODS. 

For normal and cirrhotic liver, signal intensities were measured 15 minutes after injection of Resovist (range, 1–40 μmol Fe/kg) on three different spin-echo images. Subsequently, recovery of signal intensity was monitored up to 2 weeks after injection.

RESULTS. 

The dose-dependency of efficacy was somewhat less at all doses and imaging parameters in cirrhotic liver. However, the submaximal effect was obtained at a dose of 20 μmol Fe/kg, the same as in normal liver. The rate of decay of the efficacy in cirrhotic liver was similar to or faster than that in normal liver.

CONCLUSIONS. 

The dose-dependency and rate of decay of efficacy of Resovist in cirrhosis were similar to those in normal liver, although the efficacy was less in cirrhotic liver and both the dose-dependency and rate of decay of efficacy were dependent on imaging parameters.